Furthermore, although speculative, it has recently been suggested that a proportion of patients with mismatch repair (MMR)-deficient colorectal cancer may exhibit elevated systemic inflammatory responses; 22,23 however given that only a small proportion of tumours arise through MMR deficiency, this may only account for some of the observed differences. Here, MRC1 is linked to colorectal cancer.